Global Sodium Hyaluronate Eye Drops Market Growth 2025-2031

Global Sodium Hyaluronate Eye Drops Market Growth 2025-2031

The global Sodium Hyaluronate Eye Drops market size is predicted to grow from US$ 340 million in 2025 to US$ 491 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

Sodium hyaluronate eye drops are also known as "artificial tears". They are used to relieve eye dryness and soreness.

Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.

Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.

In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.

LP Information, Inc. (LPI) ' newest research report, the “Sodium Hyaluronate Eye Drops Industry Forecast” looks at past sales and reviews total world Sodium Hyaluronate Eye Drops sales in 2024, providing a comprehensive analysis by region and market sector of projected Sodium Hyaluronate Eye Drops sales for 2025 through 2031. With Sodium Hyaluronate Eye Drops sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Hyaluronate Eye Drops industry.

This Insight Report provides a comprehensive analysis of the global Sodium Hyaluronate Eye Drops landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Hyaluronate Eye Drops portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Hyaluronate Eye Drops market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Hyaluronate Eye Drops and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Hyaluronate Eye Drops.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Hyaluronate Eye Drops market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
0.001
0.0015
0.003
Others

Segmentation by Application:
Dry Eye
Rewetting
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sodium Hyaluronate Eye Drops market?

What factors are driving Sodium Hyaluronate Eye Drops market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sodium Hyaluronate Eye Drops market opportunities vary by end market size?

How does Sodium Hyaluronate Eye Drops break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.